Bronte Capital Management Pty Ltd. has filed its 13F form on November 04, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.12 Billion distributed in 25 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Berkshire Hathaway Inc Class B with a value of $152M, Alphabet Inc. with a value of $147M, Regeneron Pharmaceuticals, Inc. with a value of $144M, Interactive Brokers Group, Inc. with a value of $116M, and Ishares Core S&P Sm Cap ETF with a value of $106M.

Examining the 13F form we can see an decrease of $58.2M in the current position value, from $1.18B to 1.12B.

Below you can find more details about Bronte Capital Management Pty Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $1.12 Billion
Financial Services: $360 Million
Communication Services: $233 Million
Healthcare: $153 Million
ETFs: $146 Million
Consumer Defensive: $106 Million
Consumer Cyclical: $75.5 Million
Basic Materials: $40.8 Million
Technology: $8.58 Million
Other: $0

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 25
  • Current Value $1.12 Billion
  • Prior Value $1.18 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 04, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 9 stocks
Track This Portfolio

Track Bronte Capital Management Pty Ltd. Portfolio

Follow Bronte Capital Management Pty Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bronte Capital Management Pty Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Bronte Capital Management Pty Ltd. with notifications on news.